Cargando…
Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response
Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), has a complex etiology that may be associated with dysbiosis of the microbiota. Previously, our study revealed significant loss of Roseburia intestinalis from the gut of untreated patients with CD...
Autores principales: | Luo, Weiwei, Shen, Zhaohua, Deng, Minzi, Li, Xiayu, Tan, Bei, Xiao, Mengwei, Wu, Shuai, Yang, Zhenyu, Zhu, Changxin, Tian, Li, Wu, Xing, Meng, Xiangrui, Quan, Yongsheng, Wang, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625378/ https://www.ncbi.nlm.nih.gov/pubmed/31173202 http://dx.doi.org/10.3892/mmr.2019.10327 |
Ejemplares similares
-
Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis
por: Zhu, Changxin, et al.
Publicado: (2018) -
Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn's disease
por: Shen, Zhaohua, et al.
Publicado: (2022) -
Roseburia intestinalis-derived flagellin ameliorates colitis by targeting miR-223-3p-mediated activation of NLRP3 inflammasome and pyroptosis
por: Wu, Xing, et al.
Publicado: (2020) -
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
por: Nie, Kai, et al.
Publicado: (2021) -
Assessment of the safety and probiotic properties of Roseburia intestinalis: A potential “Next Generation Probiotic”
por: Zhang, Chao, et al.
Publicado: (2022)